Discounted Cash Flow Rating

Strong Sell

Return on Equity Rating

Strong Sell

Debt to Equity Rating

Strong Buy

Price to Earnings Rating

Neutral

Analyst Rating

Neutral

Simple Moving Average

Strong Sell

Exponential Moving Average

Strong Sell

Relative Strength Index

Standard Deviation

Strong Buy

Williams %R

Strong Buy

Average Directional Index

Strong Sell

Insider Trading

Strong Buy

Wall Street Data Solutions Rating

Neutral

B

Curis Inc (CRIS)

Biological Products, (no Disgnostic Substances)

https://www.curis.com

Curis Inc is a biotechnology company that develops and commercializes innovative drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, advanced solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.

128 SPRING STREET, BUILDING C, SUITE 500
LEXINGTON, MA

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

08/01/2000

Market Cap

25,709,485

Shares Outstanding

5,890,000

Weighted SO

5,894,085

Total Employees

N/A

Upcoming Earnings

08/01/2024

Similar Tickers

ALRN --.--%

ALRN --.--%

ARTL --.--%

ARTL --.--%

HSTO --.--%

HSTO --.--%

TMBR --.--%

TMBR --.--%

XFOR --.--%

Beta

3.3540

Last Div

0.0000

Range

0.38-17.49

Chg

0.0600

Avg Vol

31990

Mkt Cap

25709485

Exch

NASDAQ

Country

US

Phone

617 503 6500

DCF Diff

7.5768

DCF

-3.3768

Div Yield

0.0000

P/S

2.5302

EV Multiple

-1.1504

P/FV

-36.0507

Div Yield %

0.0000

P/E

-0.5252

PEG

-3.2369

Payout

0.0000

Current Ratio

1.7827

Quick Ratio

1.7827

Cash Ratio

0.5162

DSO

91.4566

DIO

0.0000

Op Cycle

91.4566

DPO

1180.8256

CCC

-1089.3691

Gross Margin

0.9255

Op Margin

-4.8763

Pretax Margin

-4.6818

Net Margin

-4.6885

Eff Tax Rate

0.0091

ROA

-0.9450

ROE

-3.2839

ROCE

-1.5959

NI/EBT

1.0014

EBT/EBIT

0.9601

EBIT/Rev

-4.8763

Debt Ratio

0.7857

D/E

-57.0720

LT Debt/Cap

1.0241

Total Debt/Cap

1.0178

Int Coverage

-1011.1837

CF/Debt

-1.0789

Equity Multi

-72.6412

Rec Turnover

3.9910

Pay Turnover

0.3091

Inv Turnover

0.0000

FA Turnover

2.5027

Asset Turnover

0.2016

OCF/Share

-7.3446

FCF/Share

-7.3446

Cash/Share

4.8742

OCF/Sales

-4.2057

FCF/OCF

1.0000

CF Coverage

-1.0789

ST Coverage

-4.1995

CapEx Coverage

0.0000

Div&CapEx Cov

0.0000

P/BV

-36.0507

P/B

-36.0507

P/S

2.5302

P/E

-0.5252

P/FCF

-0.6016

P/OCF

-0.5855

P/CF

-0.5855

PEG

-3.2369

P/S

2.5302

EV Multiple

-1.1504

P/FV

-36.0507

DPS

0.0000

Latest Headlines (EST)

Benzinga Nov 17, 13:01 Why Dolby Laboratories Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Friday's Mid-Day Session MarketWatch Nov 17, 09:04 Curis shares rise as analysts see 'the next Pharmacyclics'

Revenue Product Segmentation